Berne, 9 August 2019
We are very grateful that the planned sponsoring agreement with Philip Morris will not be executed or has been terminated. The sponsorship of the Swiss Pavilion in Dubai 2020 by the Lausanne-based international tobacco company Philip Morris International (PMI), which was announced in July, is incomprehensible and unacceptable to our professional societies. Below is a brief explanation why our country should generally refuse to support the tobacco industry:
This letter is accompanied by a more detailed explanation of why the Federal Council should not join forces with the tobacco industry in the future (see online edition of the Schweizerische
Ärztezeitung [Swiss medical journal]). Philip Morris’s “harm reduction” strategy is an unsuitable way to combat the tobacco epidemic, as you can see from the accompanying article “Harm reduction - not an effective tobacco control strategy” recently published in the Swiss medical journal.1
We thank you for your attention to this matter and are confident that the Federal Parliament together with far-sighted authorities and politicians, will protect our minors and issue an effective Tobacco Products Act and ratify the WHO Tobacco Framework Convention.
On behalf of the Swiss Society of Pulmonology (SGP),
the Swiss Society of Pediatric Pulmonology (SGPP), the Swiss Society of Cardiology (SGK),
the Swiss Society of Pediatric Cardiology (SGPK),
the Swiss Society of Medical Oncology (SGMO ),
the Swiss Pediatric Oncology Group (SPOG)
and the Cancer Research Switzerland (KFS)
Prof. J. Barben*, PD Dr. M. Schuurmans*,
Dr. A. Zürcher*, Dr. R. Kälin*, Dr. T. Schmid*, Dr. D. Stambach (President SGPK),
Prof. C. Barazzone (President SGPP),
Prof. J. Hammer (Past President SGPP),
Prof. G. Pedrazzini (President SGK),
Prof. L. Nicod (President SGP),
Prof. M. Borner (President SGP),
Prof. R. Ammann (President SPOG),
Prof. emer. T. Cerny (President KFS)
* Members of the Special Interest Group Prevention (Tobacco/Environment) of the SGP
1 Barben, J., Schuurmans, M., Zürcher, A. et al. Harm reduction – keine wirksame Strategie zur Tabakbekämpfung. 2019;100 (31–32):1041–4.
Our website uses cookies so that we can continually improve the page and provide you with an optimized visitor experience. If you continue reading this website, you agree to the use of cookies. Further information regarding cookies can be found in the data protection note.
If you want to prevent the setting of cookies (for example, Google Analytics), you can set this up by using this browser add-on.